NCT01269684View on ClinicalTrials.gov

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Kidney Transplantation
Interventions
DRUG

Everolimus

Initial dose 1.5 mg b.i.d. Target blood trough level 4-10 ng/ml

Trial Locations (1)

Unknown

Novartis Investigative Site, Zurich

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY